The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women
Abstract
OBJECTIVE: To investigate the prospective association of low-density lipoprotein (LDL) particle diameter with the incidence of fatal and nonfatal coronary artery disease (CAD). DESIGN: A nested case-control study. SETTING: Cases and controls were identified from a population-based sample of men and women combining all of the 5 cross-sectional surveys conducted from 1979 to 1990 of the Stanford Five-City Project (FCP). PARTICIPANTS: Incident CAD cases were identified through FCP surveillance between 1979 and 1992. Controls were matched by sex, 5-year age groups, survey time point, ethnicity, and FCP treatment condition. The sample included 124 matched pairs: 90 pairs of men and 34 pairs of women. MAIN OUTCOME MEASURES: LDL peak particle diameter (LDL size) was determined by gradient gel electrophoresis on plasma samples collected during the cross-sectional surveys (stored at 70 degrees C for 5-15 years). Established CAD risk-factor data were available from FCP baseline measurements. RESULTS: LDL size was smaller among CAD cases than controls (mean +/- SD) (26.17 +/- 1.00 nm vs 26.68 +/- 0.90 nm; P<.001). The association was graded across control quintiles of LDL size. The significant case-control difference in LDL size was independent of levels of high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (non-HDL-C), triglyceride, smoking, systolic blood pressure, and body mass index, but was not significant after adjusting for the ratio of total cholesterol (TC) to HDL-C (TC:HDL-C). Among all the physiological risk factors, LDL size was the best differentiator of CAD status in conditional logistic regression. However, when added to the physiological parameters above, the TC:HDL-C ratio was found to be a stronger independent predictor of CAD status. CONCLUSION: LDL size was significantly smaller in CAD cases than in controls in a prospective, population-based study. These findings support other evidence of a role for small, dense LDL particles in the etiology of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the reduction in ratio of total to HDL cholesterol, which has been identified as a predictor of coronary heart disease (35), was not significantly different between the 2 diets.”
From Effects of Low-Carbohydrate Diets Versus Low-Fat Diets on Metabolic Risk Factors: A Meta-Analysis of Randomized Controlled Clinical Trials (2012) · cites this paper as [35]
Citations
Cites
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G. C., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K. A., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. F. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,339
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 908
NHLBI funding policies. Enhancing stability, predictability, and cost control.
Lenfant, C. L. (1994) · Circulation · doi:10.1161/01.cir.90.1.1 · Cited by 763
Graaf, J. D., Hak-Lemmers, H. L. M., Hectors, M. P. C., Demacker, P. N. M., Hendriks, J. C. M., & Stalenhoef, A. F. H. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Reaven, G. M., Chen, Y. I., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 687
Chait, A., Brazg, R., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554
Cited by
Sorted by citations
Items 801–847 of 847
Insulin Resistance, Obesity, Body Fat Distribution, and Risk of Cardiovascular Disease
Shetty, G. K., & Mantzoros, C. S. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420018905.003
Moohebati, M., Rahsepar, A. A., Tavallaie, S., Paydar, R., Fazlinezhad, A., Falsoleiman, H., Dehghani, M., & Ghayour‐Mobarhan, M. (2012)
Pignotti, P., & Giselle, A. (2013)
Hogue, J. (2004) · Corpus Université Laval (Université Laval)
Brief Review - Emerging Cardiac Biomarkers as Screening Tool for Atherosclerosis
Ahmed, S., Alawi, F., Abbas, M., & Anwar, N. (2017) · Annual Research & Review in Biology · doi:10.9734/arrb/2017/33511
“more than a three-fold increase in the risk of coronary heart disease [55,56,57,58,59, 60,61,62,63].”
BackgroundVicious eating : The food addict‘s guide to redemption
Gunnarsson, K. M. (2013)
CHAPTER 28 – Endocannabinoid Receptor Blockers
Despres, J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50032-9
The atherogenic lipoprotein phenotype in renal disease
Deighan, C. J. (1999) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.71278
Lipide und PCSK9-Inhibition bei chronischer Nierenerkrankung
Schunk, S. J., Fliser, D., & Speer, T. (2020) · Der Nephrologe · doi:10.1007/s11560-020-00421-x
How ApoB Measurements Could Improve Prevention of Cardiovascular Disease
Sniderman, A. D. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_29
The Cardiovascular Consequences of Type 2 Diabetes Mellitus
Golden, S. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_5
Fonseca, M. I. H. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2021.tde-29122021-150846
Le, N., & Brown, W. V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-878-6_28
MacKenzie, B. R., Croxson, R. S., & Cumming, G. R. (2000) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-14499-0_21
(2018) · Wiley eBooks · doi:10.1002/9781118829875.refs
Quispe, R., Das, T. M., & Michos, E. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-75055-8_2
Dairy Foods and Cardiovascular Health
(1999) · CRC Press eBooks · doi:10.1201/9781420050189.ch2
(2002) · Circulation · doi:10.1161/circ.106.25.3373
The Newer Coronary Risk Factors
Wilson, P. W. F. (2000) · doi:10.1007/978-1-4757-9310-9_10
(2005) · Wiley eBooks · doi:10.1002/9780470774663.refs
Synergy of Portfolio Diet Components and Drugs in Coronary Heart Disease
Marchie, A., Emam, A., Kendall, C. W. C., Wong, J. M., Jenkins, D. J. A., & de Souza, R. J. (2005) · CRC Press eBooks · doi:10.1201/9781420038255.ch4
Nonalcoholic fatty liver disease and cardiovascular disease
Koseki, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-817394-7.00011-5
Wu, Z. E., Fraser, K., Kruger, M. C., Sequeira, I. R., Yip, W. C. Y., Lu, L. W., Plank, L. D., Murphy, R., Cooper, G. J. S., Martin, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13245853
Tian, Y., Wang, J., Liu, Y., Luo, X., Yao, Z., Wang, X., Zhang, Y., Xu, C. Y., & Zhao, X. (2021) · Figshare · doi:10.6084/m9.figshare.14235123
Tian, Y., Wang, J., Liu, Y., Luo, X., Yao, Z., Wang, X., Zhang, Y., Xu, C., & Zhao, X. (2021) · Figshare · doi:10.6084/m9.figshare.14235126
Omega-3 index in patients with severe diabetic ocular complications
Guttmann, A., Wallisch, F., Hoeflechner, L., Pahljina, C., Lindner, M., Wedrich, A., Lindner, E., & Ivastinović, D. (2024) · Spektrum der Augenheilkunde · doi:10.1007/s00717-024-00574-3
Voltolini, E. (2025) · EPITAYA eBooks · doi:10.47879/ed.ep.2025820p291
Common Uses of Multivariable Models
Katz, M. H. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009558488.003
Campos, H., & Sacks, F. M. (2002) · JAMA · doi:10.1001/jama.287.6.712-a
Neto, R., & Pinto, A. F. (2000) · Americanae (AECID Library)
Johnston, N. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Cao, J., Wang, Z., Zhu, M., Huang, Y., Jin, Z., & Xiong, Z. (2023) · Figshare · doi:10.6084/m9.figshare.23812571
Wu, Z. E., Fraser, K., Kruger, M. C., Sequeira, I. R., Yip, W. C. Y., Lu, L. W., Plank, L. D., Murphy, R., Cooper, G. J. S., Martin, J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13245850
Zhou, P., Shen, Y., Wang, L., Cao, Z., Feng, W., Liu, J., Wang, L., Meng, P., Yang, J., Xu, W.-Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12731551
Mécanismes impliqués dans le remodelage artériel associé à la maladie rénale chronique
Garnier, A. (2023) · theses.fr (ABES) · doi:10.70675/32e03265z29c6z4f8fzbbbfz3d6744abf06a
Ji, H., Zhao, Z., Li, R., Ma, W., Zhang, M., & Zhou, Z. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1849520
“Low HDL-C fails to efficiently remove oxidative byproducts, further aggravating vascular injury (61, 62).”
Kathariya, G., Aggarwal, J., & Sreenivas Reddy, S. (2026) · Indian Journal of Cardiology · doi:10.4103/ijoc.ijoc_9_26
The Clinical Significance of Small, Dense Low-Density Lipoproteins
Rizzo, M., & Berneis, K. K. (2006) · Springer eBooks · doi:10.1007/0-387-36279-3_9
“A predominance of small dense LDL particles has been identified as being associated with a higher risk of CHD in the Physician’s Health Study [52], the population based on Stanford Five Cities Project [ 53 ] and the Quebec Cardiovascular Study [54, 55].”
BackgroundMethodVakkilainen, J. (2002) · Työväentutkimus Vuosikirja
Shaheen, H. A. (2020) · doi:10.34917/4332607
“For example large VLDL, small LDL and small HDL particle concentrations are positively associated with CVD, while large LDL particle concentrations are negatively associated with CVD (Blake et al., 2002; Freedman et al., 1998; Gardner et al., 2002; Jeyarajah et al., 2006).”
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Laffel (1999) · doi:10.1002/(sici)1520-7560(199911/12)15:6
Metadata
- Authors
- Gardner, C. D.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Gardner, Christopher D.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1996-09-18
- Volume
- 276
- Issue
- 11
- Pages
- 875
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2050758709
- Cited by
- 843
- References
- 53
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 10 · 2021: 16 · 2020: 23 · 2019: 14 · 2018: 7 · 2017: 16 · 2016: 10 · 2015: 23 · 2014: 14 · 2013: 33 · 2012: 22
- FWCI
- 37.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl018574-26, 5r01hl021906-19)
- National Heart, Lung, and Blood Institute (T32HL007034, HL21906, HL-18574, 5 T32 HL07034)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- small dense LDL, LDL particle size, coronary artery disease, atherosclerosis, cardiovascular risk factors, TC/HDL-C ratio, HDL cholesterol, non-HDL cholesterol, triglycerides, sex differences
- MeSH terms
- Adult, Aged, Coronary Disease, Cross-Sectional Studies, Electrophoresis, Polyacrylamide Gel, Female, Humans, Lipids, Lipoproteins, LDL, Male, Middle Aged, Prospective Studies, Risk Factors, Body Mass Index, Incidence, Linear Models, Logistic Models, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review